A randomized, open-label, single-dose, pilot study to evaluate the safety and efficacy of OROS hydromorphone in patients with acute, moderate-to-severe postoperative pain.

Trial Profile

A randomized, open-label, single-dose, pilot study to evaluate the safety and efficacy of OROS hydromorphone in patients with acute, moderate-to-severe postoperative pain.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2009

At a glance

  • Drugs Hydromorphone (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors ALZA Corporation
  • Most Recent Events

    • 21 Jul 2009 Actual patient number (50) added as reported by ClinicalTrials.gov.
    • 08 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top